|
|
Clinical Research
Center
Publications
MHCRC Publications
1984-1999
1.
Ahearn EP, Steffens DC, Cassidy F, Van Meter SA, Provenzale JM,
Seldin MF, Weisler RH, Krishnan KR. Familial leukoencephalopathy in bipolar
disorder. Am J Psychiatry
155(11):1605-1607, November 1998.
2.
Bissette G, Seidler FJ,
Nemeroff CB, and Slotkin TA. High affinity choline transporter status
in alzheimers disease tissue from rapid autopsy.
Annals of the New York Academy of Sciences 777:197-204, 1996.
3.
Blakely
RD, Berson HE, Fremeau Jr RT,
Caron MG,
Peek MM, Prince HK, Bradley
CC. Cloning and expression of a functional serotonin transporter from rat
brain. Nature 354:66-70, 1991.
4.
Blazer
D. Clinical features in
depression in old age: a case of
minor depression. Current
Opinion in Psychiatry 4:596-599, 1991.
5.
Blazer
D. Depression in late life. Current
Opinion in Psychiatry 2:515-519, 1989.
6.
Blazer
D. Depression in the elderly.
New England Journal of Medicine 320:14-166, 1989.
7.
Blazer
D. General principles in aging. In:
Geriatrics Review Syllabus:
A Core Curriculum in Geriatric Medicine; Book I, Syllabus and Questions,
JC Beck, (ed.), American Geriatrics Society, New York, New York, 1989-90
Program.
8.
Blazer
D, Bachar JR, Hughes DC. Major depression with melancholia: a comparison of
middle-aged and elderly adults. Journal
of the American Geriatrics Society. 35(10):927-32, 1987.
9.
Blazer
D, Hughes DC. Subjective social support and depressive symptoms in major
depression: separate phenomena or epiphenomena. Journal of Psychiatric
Research, 25(4):191-203,
1991.
10.
Blazer
D, Hughes DC, Fowler N.
Anxiety as an outcome symptom of depression in elderly and middle-aged
adults. Intl Journal of
Geriatric Psychiatry 4:273-278, 1989.
11.
Blazer
D, Hughes DC, George LK. Age and
impaired subjective support: predictors
of depressive symptoms at one-year follow-up.
The Journal of Nervous and Mental Disease 180(3):172-178, 1992.
12.
Blazer
D, Swartz, M, Woodbury M,
Manton KG, Hughes D,
George LK.
Depressive symptoms and depressive diagnoses in a community
population. Arch Gen
Psychiatry 45:1078-1084, 1988.
13.
Blazer
D, Woodbury M, Hughes DC, George LK, Manton KG, Bachar JR,
Fowler N. A statistical analysis of the classification of depression in
a mixed community and clinical sample. Journal
of Affective Disorders 16:11-20, 1989.
14.
Broadhead
WE, Tse C-KJ, Burns BJ, Sigmon A, Yarnall KSH,
Walker R. Three month follow-up of minor depression in family practice.
Seventh Annual NIMH International Research Conference on Mental Health
Problems in the General Health Sector, 1993.
15.
Broadhead
WE, Weissman MM, Barrett JE, Blacklow RS, Gilbert TT, Keller MB, Higgins, E. The
SDDS-PCTM screening questionnaire for multiple mental disorders in
primary care: A validation study.
Seventh Annual NIMH International Research Conference on Mental Health
Problems in the General Health Sector, 1993.
16.
Brummett
BH, Barefoot JC, Siegler IC, Steffens DC.
The relation of subjective and received social support to clinical and
self-report assessments of depression in an elderly population.
J. Consulting Clinical Psychology (in press).
17.
Carroll
BJ. Brain mechanisms in manic depression. Clinical Chemistry
40(2):303-8, 1994
18.
Carroll
BJ. Diagnostic validity
and laboratory studies. Rules of the game. In:
The Validity of Psychiatry Diagnosis, Robins LN, Barrett JE, (eds.),
Raven Press, New York, 229-245, 1989.
19.
Carroll
BJ. Psychopathology and
neurobiology of manic-depressive disorders.
In: Psychopathology and the Brain.
BJ Carroll and JE Barrett (eds.), Raven Press, New York, 265-285,
1991.
20.
Charles HC, Lazeyras F, Krishnan KRR, Boyko OB, Patterson LJ,
Doraiswamy PM, McDonald WM. Proton
spectroscopy of human brain: effects of age and sex.
Prog Neuro-psychopharmacol. & Biol Psychia 18(6):995-1004,
1994.
21.
Charles HC, Lazeyras F, Krishnan KRR, Boyko OB, Payne M, Moore D.
Brain choline in depression: In
vivo detection of potential pharmacodynamic effects of antidepressant
therapy using hydrogen localized spectroscopy.
Prog. Neuro-Psychopharmacol & Biol Psy 18(7), 1994.
22.
Clark LM, McDonald WM, Welsh-Bohmer KA, Siegler IC, Dawson DV,
Tupler LA, Krishnan KR. Magnetic
resonance imaging correlates of depression in early- and late-onset
alzheimer's disease. Biol
Psychiatry 1998 Oct 1:44(7):592-599.
23.
Coffey
CE, Wilkinson WE,
Weiner RD, Parashos JA,
Djang WT, Webb MC,
Figiel GS, Spritzer CE.
Quantitative cerebral anatomy in depression: a controlled magnetic resonance
imaging study. Arch Gen
Psychiatry, 50:7-16, 1993.
24.
Craighead
WE and Craighead LW. Behavior
therapy: recent developments. Current
Opinion in Psychiatry 3:785-789, 1990.
25.
Craighead WE and Evans DD. Factor
analysis of the Montgromery-Asberg depression rating scale.
Depression 4:31-33, 1996.
26.
Craighead
WE, Evans DD, Robins, CJ. Unipolar depression. In: SM Turner, KS Calhoun, HE
Adams (eds.), Handbook of Clinical Behavior Therapy (2nd ed., pp.
99-116), New York: John Wiley
& Sons, 1992.
27.
Davidson JRT, Boyko OB,
Charles HC, Krishnan KRR, Potts N, Ford SM, Patterson LA. MRS in social
phobia: preliminary findings. J
Clin Psychiatry 54(12):19-25, 1993.
28.
Dearry
A, Gingrich JA, Falardeau P,
Fremeau Jr RT, Bates MD, Caron
MG. Molecular cloning and
expression of the gene for a human D1 dopamine receptor.
Nature, 347(6288), 72-76, 1990.
29.
Doraiswamy PM, Tupler LA,
Krishnan KR. Neuroleptic
treatment and caudate plasticity. The
Lancet 345(8951):734-735, March 1995.
30.
Doraiswamy PM, Patterson L, Na C, Husain MM, Boyko O, McDonald WM,
Krishnan KRR. Bicaudate index on magnetic resonance imaging: effects of normal
aging. J
Geriatric Psychiatry and Neurology 7(1):13-17, 1994.
31.
Escalona
PR, Early B, McDonald WM,
Doraiswamy PM, Shah SA, Husain MM, Boyko
OB, Figiel GS,
Ellinwood EH, Nemeroff CB,
Krishnan KRR. Reduction of
cerebellar volume in major depression: a controlled MRI study. Depression 1:156-158,
1993.
32.
Figiel
GS, Coffey CE, Weiner, RD. Brain
magnetic resonance imaging in elderly depressed patients receiving
electroconvulsive therapy. Convulsive
Therapy 5(1):26-34, 1989.
33.
Flint
DP, Hays JC, Krishnan, KRR, Meador KG, Blazer, DG. Suicidal behaviors in depressed men with a family history of
suicide: effects of psychosocial
factors and age. Aging and
Mental Health 2:286-299, 1998.
34.
Fumagalli F, Jones SR, Caron MG, Seidler
FJ, Slotkin TA. Expression of mRNA coding for the serotonin transporter in
aged vs. young rat brain: differential effects of glucocorticoids.
Brain Research 719:225-228, 1996.
35.
George
LK. Social and economic factors
related to psychiatric disorders in late life.
In: Geriatric Psychiatry,
Chapter 8, Busse EW and Blazer DG, eds. Washington,
DC, American Psychiatric Press, 1989.
36.
George LK. Social factors
and depression in late life. In: Schneider LS, Reynolds CF,
Lebowitz B, Friedhoff A., eds. Diagnosis
and Treatment of Depression in the Elderly:
Proceedings of the NIH Consensus Development Conference, Chapter 9,
Washington DC: American
Psychiatric Press, in press.
37.
George
LK. Social factors and the onset
and outcome of depression. In:
Schaie KW, Hause JS, Blazer, DG, eds. Aging,
Health Behaviors, and Health Outcomes. Hillsdale
NJ: Lawrence Erlbaum Associates,
137-159, 1992.
38.
George
LK, Blazer DG, Hughes DC, Fowler N. Social
support and the outcome of major depression.
British Journal of Psychiatry 154:478-485, 1989.
39.
Gingrich
JA, Andersen PH, Tiberi M,
El-Mestikawy S, Jorgensen PN, Fremeau Jr RT,
Caron MG. Identification, characterization, and molecular cloning of a
novel transporter-like protein localized to the central nervous system.
FEBS 312(2,3) 115-122, 1992.
40.
Giros
B, El-Mestikawy
S, Bertrand L,
Caron MG. Cloning and
functional characterization of a cocaine-sensitive dopamine transporter.
FEBS 295(1,2,3):149-154, 1991.
41.
Giros
B, and Caron MG. Molecular
characterization of the dopamine transporter.
Trends in Pharmacological Sciences 14(2):43-49, 1993.
42.
Giros
B, El-Mestikawy S, Godinot N, Zheng K, Han H, Yang-Feng T, Caron, MG. Cloning,
pharmacological characterization, and chromosome assignment of the human
dopamine transporter. Molecular
Pharmacology 42:383-390, 1992.
43.
Gonzalez MB, Snyderman TB, Colker JT,
Arias, RM, Jian JW, O’Connor CM, and Krishnan R. Depression in
patients with coronary artery disease. Depression
4:57-62, 1996.
44.
Greenwald BS, Kramer-Ginsberg E, Krishnan , KRR,
Ashtari M, Aupperle PM,
and Patel M. MRI signal hyperintensities in geriatric depression.
American Journal of Psychiatry 153:9, September 1996.
45.
Greenwald
BS, Kramer-Ginsberg E, Krishnan KRR, Ashtari M, Aupperle PM, Patel M. Magnetic
resonance imaging signal hyperintensities in geriatric depression.
American J Psychiatry 153:1212-1215, 1996.
46.
Greenwald BS, Kramer-Ginsberg E, Krishnan KRR, Ashtari M, Aupperle PM,
and Patel M. MRI signal hyperintensities in geriatric depression. Am J Psychiatry 153:9, 1996.
47.
Hays JC, Krishnan KRR,
George LK, Pieper, CF, Flint EP, Blazer DG. Psychosocial and physical
correlates of chronic depression. Psychiatry
Research 72:149-159, 1997.
48.
Hays JC, Krishnan KRR, George LK, Blazer DG.
Age of first onset of bipolar disorder: demographic, family history and
psychosocial correlates. Depression
and Anxiety 7:76-82, 1998.
49.
Hays JC, Landerman RL, George LK, Flint EP, Koenig H, Blazer DG.
Social correlates of the dimensions of depression in the elderly.
Journals of Gerontology: Psychological Sciences 53B:31-39, 1998.
50.
Hays JC,
Saunders WB, Flint EP, Kaplan BH, Blazer DG. Social support and depression as risk factors for loss of
physical function in late life. Aging
and Mental Health 1:209-220, 1997.
51.
Hughes
DC, DeMallie D, Blazer DG.
Does age make a difference in the effects of physical health and social
support on the outcome of a major depressive episode?
Am. J. Psychiatry 150:728-733, 1993.
52.
Keshavan
MS, Anderson S, Beckwith C, Nash K, Pettegrew JW, Krishnan KR. A comparison of
stereology and segmentation techniques for volumetric measurements of lateral
ventricles in magnetic resonance imaging.
Psychiatry Research 61(1):53-60, 1995.
53.
Koenig
HG, Cohen HJ, Blazer DG, Krishnan KRR, Sibert TE. Profile of depressive symptoms in younger and older
medical inpatients with major depression.
J Am Geriatrics Society 41(11):1169-1176, 1993.
54.
Koenig
HG, Meador KG, Cohen HJ, Blazer DG. Screening for depression in hospitalized
elderly medical patients: taking
a closer look. J. Amer. Ger.
Soc. 40(10):1013-1017, 1992.
55.
Krishnan
KRR. Depression-neuroanatomical substrates.
Behavior Therapy 23:571-583, 1992.
56.
Krishnan KR, George LK, Pieper CF, Jiang W, Arias R, Look A,
O'Connor C. Depression and social
support in elderly patients with cardiac disease. American Heart Journal 136(3):491-495, September 1998.
57.
Krishnan KR, Hays JC, George LK, Blazer DG.
Six-month outcomes for MRI-related vascular depression.
Depress Anxiety 8(4):142-146,
1998.
58.
Krishnan
KR, Tupler LA, McDonald WM. Background
factors and clinical symptoms of major depression with silent cerebral
infarction. Stroke
25(12):2507, 1994.
59.
Krishnan KRR, Hays JC,
Blazer DG. MRI-defined
vascular depression. American
Journal of Psychiatry 154(4):497-501, April 1997.
60.
Krishnan
KRR, Ritchie JC, Saunders W,
Wilson W, Nemeroff CB, and
Carroll BJ. Nocturnal and early morning secretion of ACTH and cortisol in
humans. Biological Psychiatry
28:47-57, 1990.
61.
Krishnan
KRR, McDonald WM, Escalona PR,
Doraiswamy PM, Na C, Husain MM,
Figiel GS, Boyko OB, Ellinwood
EH, Nemeroff CB. Magnetic resonance imaging of the caudate nuclei in
depression. Arch Gen
Psychiatry 49:553-557, 1992.
62.
Krishnan
KRR, McDonald WM, Tupler LA, Boyko OB. Neuroanatomical
substrates of depression in the elderly.
Eur Arch Psychiatry and Clinical Neuroscience 243:41-46, 1993.
63.
Krishnan KRR, McDonald WM. Arteriosclerotic
depression. Medical Hypotheses
44(2):77-145, 1995.
64.
Krishnan
KRR, Miller MN, Helms MJ, Reed D, Ritchie
JC, Nemeroff CB,
Carroll BJ. Dose response relationship between plasma ACTH and cortisol
after the infusion of ACTH1-24. Eur.
Arch Psychiatry Clin. Neurosci. 242:240-243, 1993.
65.
Krishnan KRR, Tupler LA, Ritchie, Jr. JC, McDonald WM, Knight DL,
Nemeroff CB, Carroll BJ. ApoE-e4
frequency in geriatric depression. Biol.
Psy 40:69-71, 1996.
66.
Krishnan
KRR. Neuroanatomic substrates of
depression in the elderly. J.
Ger. Psychiatry and Neurology 6:39-58, 1993.
67.
Krishnan
KRR. Organic bases of depression
in the elderly. Annu. Rev.
Med. 42:261-66, 1991.
68.
Krishnan
R, Ritchie JC, Saunders WB, Nemeroff CB, Carroll BJ. Adrenocortical
sensitivity to low-dose ACTH administration in depression patients.
Biological Psychiatry 27:930-933, 1990.
69.
Krishnan, KRR, Hays, JC, Tupler, LA, George, LK, and Blazer, DG.
Clinical and phenomenological comparisons of late-onset and early-onset
depression. Am J Psychiatry
152(5):785-788, 1995.
70.
Lynch T, Johnson C, Mendelson T, Robin C, Krishnan R and Blazer D. Correlates
of suicide among an elderly depressed sample.
Journal of Affective Disorders, 1998, (in press).
71.
Lynch T, Johnson C, Mendelson T, Robin C, Krishnan R and Blazer D. New onset and remission of suicidal ideation.
Journal of Affective Disorders, 1998, (in press).
72.
Lynch T, Johnson C, Mendelson T, Robin C, Krishnan R and Blazer D. Perceived social support among depressed elderly, middle-aged
and young adult samples. Journal
of Affective Disorders, 1998, (in press).
73.
MacFall
JR, Byrum C, Parashos I, Charles HC, Boyko OB, Chittilla V, Krishnan KRR.
Relative accuracy and reproductibility of regional MRI brain volumes
for point-counting methods. Psychiatry
Research 55:167-177, 1994.
74.
McDonald
WM, Krishnan KRR, Doraiswamy PM, Blazer
DG. Occurrence of subcortical
hyperintensities in elderly subjects with mania.
Psychiatry
Research: Neuroimaging
40:211-20, 1991.
75.
Miner CM,
Davidson JRT, Potts NLS, Tupler LA, Charles HC, Krishnan KRR.
Brain fluoxetine measurements using Magnetic Resonance Spectroscopy in
patients with social phobia. Biol
Psychiatry 38:696-698, 1995.
76.
Nemeroff CB,
Knight DL, Franks J,
Craighead WE, and Krishnan KRK. Further
studies on platelet serotonin transporter binding in depression.
Am J. Psychiatry 151:(11), 1623-1625, November 1994.
77.
Nemeroff
CB, Knight DL, Krishnan KRR, Slotkin
TA, Bissette G, Melville ML,
Blazer DG. Marked reduction in
the number of platelet-tritiated imipramine binding sites in geriatric
depression. Arch Gen
Psychiatry 45:919-923, 1988.
78.
Parashos
IA, Oxley SL, Boyko OB, Krishnan KRR. In
vivo quantitation of basal ganglia and thalamic degenerative changes in
two temporal lobectomy patients with affective disorder.
J Neuropsychiatry and Clinical Neurosci 5(3):337-341, 1993.
79.
Parashos IA, Tupler LA, Blitchington T, Krishnan KR.
Magnetic-resonance morphometry in patients with major depression.
Psychiatry Res 9:84(1):7-15,
1998
80.
Rajagopalan P, Krishnan KR, Passe TJ, MacFall JR.
Magentic resonance using deoxyhemoglobin contrast versus positron
emission tomography in the assessment of brain function.
Prog Neuropsychopharmacol Biol Psychiatry 19(3):351-366, 1995.
81.
Rajagopalan P, Passe TJ, Doraiswamy PM, Figiel GS, MacFall JR, and
Krishnan, KRR. Changes in pituitary gland signal intensity and morphology as
evaluated by magnetic resonance imaging in aging, depression, and by gender.
Depression 2:303-307, 1994-95.
82.
Rao VP,
Krishnan KRR, Goli V, Saunders WB, Ellinwood
Jr EH, Blazer DG,
and Nemeroff CB. Neuroanatomical changes and hypothalamo-pituitary-adrenal
axis abnormalities. Biol
Psychiatry 26:729-732, 1989.
83.
Renick SE, Seidler FJ, McCook EC, and Slotkin TA. Neuronal control of
cardiac and hepatic macromolecule synthesis in the neonatal rat:
effects of sympathectomy. Pediatric
Research 41:359-363, 1997.
84.
Ritchie
JC, Owens MJ, Mayer H, Watson JT,
Kilts C, Carroll BJ. Preliminary
studies of 6b-hydroxydexamethasone and its importance in
the DST. Biological
Psychiatry 32:825-833, 1992.
85.
Ritchie
JC, Belkin BM, Krishnan KRR, Nemeroff CB, Carroll BJ. Plasma dexamethasone concentrations and the dexamethasone
suppression test. Biological Psychiatry 27:159-173,
1990.
86.
Roy TS, Andrews JE, Seidler FJ, Slotkin TA.
Chlorpyrifos elicits mitotic abnormalities and apoptosis in
neuroepithelium of cultured rat embryos.
Teratology 58(2):62-68, 1998.
87.
Roy TS, Andrews JE, Seidler FJ, Slotkin TA. Nicotine evokes cell
death in embryonic rat brain during neurulation. J Pharmacol Exp Ther 1998 Dec;287(3):1136-1144.
88.
Shedlack KJ, Eun-Kyu L, Radtke RA, Friedman AH, Crain JB, Boyko OB,
Krishnan KRR. Ipsilateral subcortical atropy associated with temporal
lobectomy. Psychiatry
Research: Neuroimaging 54:295-304,1994.
89.
Shedlack KJ, McDonald WM, Laskowitz, DT, Krishnan, KRR.
Geniculocalcarine hyperintensities on brain magnetic resonance imaging
associated with visual hallucinations in the elderly.
Psychiatry Research: Neuroimaging 54:283-293, 1994.
90.
Slotkin TA,
Hays JC, Nemeroff CB, and Carroll BJ.
Dexamethasone suppression test identifies a subset of elderly depressed
patients with reduced platelet serotonin transport and resistance to
imipramine inhibition of transport. Depression
and Anxiety 6:19-25, 1997.
91.
Slotkin TA, Nemeroff CB,
Bissette G, and Seidler FJ.
Overexpression of the high affinity choline transporter in cortical
regions affected by alzheimer’s disease: evidence from rapid autopsy
studies. Journal of Clinical
Investigation 94:696-702, 1994.
92.
Slotkin TA, Zhang J. McCook
EC, and Seidler FJ.
Glucocorticoid-targeting of the adenylyl cyclase signaling pathway in
the cerebellum of young versus aged rats. Brain
Research, 800:236-244, 1998.
93.
Slotkin TA, Barnes GA,
McCook EC, Seidler FJ. Programming of brainstem serotonin transporter
development by pernatal glucocorticoids.
Developmental Brain Research 93:155-161, 1996.
94.
Slotkin TA, Lorber BA,
McCook EC, Barnes GA,
and Seidler FJ.
Neural input and the development of adrenergic cell signaling:
neonatal denervation evokes neither receptor upregulation nor
persistent supersensitivity of adenylate cyclase.
Developmental Brain Research 88:17-29, 1995.
95.
Slotkin
TA, McCook EC,
Seidler FJ. Glucocorticoids regulate the development of intracellular
signaling: enhanced forebrain adenylate cyclase catalytic subunit activity
after fetal dexamethasone exposure. Brain
Research Bulletin 32:359-362, 1993.
96.
Slotkin TA, McCook EC,
Ritchie JC, and Seidler FJ. Do
glucocorticoids contribute to the abnormalities in serotonin transporter
expression and function seen in depression?
An animal model. Biological
Psychiatry 40:576-584, 1996.
97.
Slotkin TA, Miller DB,
Fumagalli F, McCook EC, Zhang
J, Bissette G, and Seidler FJ.
Modeling geriatric depression in animals:
biochemical and behavioral effects of olfactory bulbectomy in young versus
aged rats. Journal of
Pharmacology and Experimental Therapeutics 289:334-345,1999.
98.
Slotkin TA, Saleh JL,
Zhang J, and Seidler FJ.
Ontogeny of b-adrenoceptor/adenylyl
cyclase desensitization mechanisms: the
role of neonatal innervation. Brain
Research 742:317-328, 1996.
99.
Slotkin
TA, Whitmore WL,
Barnes GA, Krishnan KRR, Blazer DG,
Knight DL, Nemeroff CB.
Reduced inhibitory effect of imipramine on radiolabeled serotonin
uptake into platelets in geriatric depression.
Biol. Psychiatry,
25:687-691, 1989.
100.
Slotkin
TA, Lappi SE, McCook EC, Tayyeb
MI, Eylers JP,
Seidler FJ. Glucocorticoids and the development of neuronal function:
effects of prenatal dexamethasone exposure on central noradrenergic
activity. Biol. Neonate
61:326-336, 1992.
101.
Slotkin
TA, Lappi SE, Tayyeb MI, Seidler
FJ. Dose-dependent glucocorticoid
effects on noradrenergic synaptogenesis in rat brain: ontogeny of [3H]desmethylimipramine binding sites
after fetal exposure to dexamethasone.
Research Communications in Chemical Pathology and Pharmacology
73(1):3-19, 1991.
102.
Slotkin
TA, McCook EC, Nemeroff CB, Seidler, FJ. Species differences in a2-adrenergic
regulation of platelet adenylate cyclase.
Research Communications in Chemical Pathology and Pharmacology 72(3):259-271, 1991.
103.
Slotkin TA, McCook EC, Seidler FJ. Cryptic brain cell injury caused by fetal nicotine exposure
is associated with persistent elevations of c-fos
protooncogene expression. Brain
Research 750:180-188, 1997.
104.
Slotkin TA, McCook EC, Ritchie JC, Carroll BJ, Seidler FJ. Serotonin transporter expression in rat brain regions and
blood platelets: aging and
clucocorticoid effects. Biological
Psychiatry 41:172-183, 1997.
105.
Slotkin TA, Seidler FJ, Ritchie JC. Effects of aging and glucocorticoid treatment on monoamine
oxidase subtypes in rat cerebral cortex: therapeutic implications.
Brain Res Bull 1:47(4):345-348, November 1998.
106.
Slotkin TA, Thai L, McCook
EC, Saleh JL, Zhang J, and Seidler FJ. Aging and glucocorticoids:
effects on cell signaling mediated through adenylyl cyclase.
The Journal of Pharmacology and Experimental Therapeutics
279(2):478-491, 1996.
107.
Slotkin TA, Zhang J, McCook EC, Seidler FJ.
Glucocorticoid administration alters nuclear transcription factors in
fetal rat brain: implications for the use of antenatal steroids.
Brain Res Dev Brain Res 1:111(1):11-24, November 1998.
108.
Soares
JC, Krishnan KRR, Keshavan MS. Nuclear magnetic resonance spectroscopy: new insights into the pathophysiology of mood disorder.
Depression 4:14-30, 1996.
109.
Steffens DC, Hays JC, Krishnan KRR. Disability in geriatric
depression. Am J Geriatr
Psychiatry 7:34-40, 1997.
110.
Steffens
DC, O'Connor CM, Jiang WJ, Pieper CF, Kuchibhatla MN, Arias RM, Look A,
Davenport C, Gonzalez MB, Krishnan KRR. The
effect of major depression on functional status in patients with coronary
artery disease. J Am Geriatr
Soc 47(3):319-322, 1999. Poster
presentation at 51st Annual Meeting, Gerontological Society of America,
Philadelphia, November, 1998.
111.
Steffens DS, Hays JC, George
LK, Krishnan KRR and Blazer DG.
Sociodemographic and clinical correlates of number of previous
depressive episodes in the depressed elderly.
Journal of Affective Disorders, 39:99-106, 1996.
112.
Thai L, Galluzzo JM, McCook EC, Seidler FJ, and Slotkin TA.
Atypical regulation of hepatic adenylyl cyclase and adrenergic
receptors during a critical developmental period:
agonists evoke supersensitivity accompanied by failure of receptor
down-regulation. Pediatric
Research 39:697-707, 1996.
113.
Thakur M and Krishnan KRR. Delusional
and non-delusional depression in the elderly – a comparative study.
Psychiatry Research, 1998, (in press).
114.
Thakur
M, Hays J, Krishnan RR. Clinical,
demographic and social characteristics of psychotic depression. Psychiatry Research 86: 99-106, 1999.
115.
Tiberi
M, Jarvie KR, Silvia C, Falardeau P, Gingrich
JA, Godinot N, Bertrand L, Yang-Feng TL,
Fremeau Jr RT, Caron, MR. Cloning,
molecular characterization, and chromosomal assignment of a gene encoding a
second d1 dopamine receptor subtype: differential expression pattern in rat brain compared with
the D1a receptor. Proc. Natl. Acad. Sci, USA, 88, 7491-7495, 1991.
116.
Trauth JA, Seidler FJ, McCook EC, Slotkin TA.
Persistent c-fos induction by nicotine in developing rat brain regions:
interaction with hypoxia. Pediatr
Res. 45(1):38-45, 1999.
117.
Turnbull JE, George LK, Landerman R, Swartz MS, Blazer DG. Social outcomes related to age of onset among psychiatric
disorders. J. Consult. and
Clin. Psychology 58(6):832-839, 1990.
118.
Watkins LL, Kuchibhatla M, Davenport C, Krishnan KRR. Generalized
anxiety disorder in coronary artery disease patients: effects of low social support and negative life events.
J Psychosomatic
Research (under review) 1999.
119.
Xanthakos S, Krishnan KRR, Kim D, Charles HC. Magnetic resonance
imaging of alzheimer’s disease. Prog
Neuro-Psychopharmaol & Biol Psychiat 20:597-626, 1996.
120.
Zeiders JL,
Seidler FJ, and Slotkin
TA. Ontogeny of regulatory mechanisms for b-adrenoceptor control of rat cardiac adenylyl cyclase:
targeting of G-proteins and the cyclase catalytic subunit.
Journal of Molecular and Cellular Cardiology 29:603-615, 1997.
Please submit all corrections and/or
additions to Karen L Taylor/Psych/mc/Duke@mc
Karen L. Taylor
Return
to top of the page
Back
to the CRC
|